SUPERNUS

LIVE

Serial Number

78558827

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Gregory S. Bernabeo

First Use Date

Mar 21, 2007

Filing Date

Feb 2, 2005

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SUPERNUS Trademark

Serial Number: 78558827 • Registration: 3349448

SUPERNUS is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on February 2, 2005. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

SHIRE LABORATORIES INC. (21 trademarks)

1550 East Gude Drive
Rockville, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Gregory S. Bernabeo

984 trademarks filed View all →

Trademark Details

Filing Date

February 2, 2005

Registration Date

December 4, 2007

First Use Anywhere

March 21, 2007

First Use in Commerce

March 21, 2007

Published for Opposition

May 16, 2006

Goods & Services

Pharmaceuticals preparations for the treatment of central nervous system disorders

[ Chemicals and excipients used in the manufacture of pharmaceuticals, namely, formulations which promote controlled release, reduced abuse potential, enhanced solubility, enhanced permeability or enhanced absorption of pharmaceutical agents ]

[ Pharmaceutical drug development; pharmaceutical drug development and research services, namely, drug screening services; pharmaceutical development services for others, namely, evaluating the permeability and absorption of pharmaceuticals in the body and developing formulations to facilitate and improve the delivery of drugs into the body; pharmaceutical research and development services, namely, cell-based in vitro and in vivo screening services ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Nov 20, 2017 NAS8

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Nov 20, 2017 RNL1

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

Nov 20, 2017 9G8P

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

Nov 20, 2017 8PRT

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Nov 20, 2017 APRE

TEAS SECTION 8 & 9 RECEIVED

Oct 24, 2017 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Dec 4, 2016 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Dec 30, 2013 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Dec 30, 2013 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 30, 2013 APRE

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

Dec 19, 2013 815F

TEAS SECTION 8 & 15 RECEIVED

Dec 19, 2013 E815

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Dec 17, 2013 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 18, 2010 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 18, 2010 REAP

REGISTERED-PRINCIPAL REGISTER

Dec 4, 2007 R.PR

LAW OFFICE REGISTRATION REVIEW COMPLETED

Oct 29, 2007 REGV

ASSIGNED TO LIE

Oct 25, 2007 ALIE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 25, 2007 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Sep 20, 2007 SUPC

USE AMENDMENT FILED

Aug 8, 2007 IUAF

PAPER RECEIVED

Aug 8, 2007 MAIL

SOU EXTENSION 1 GRANTED

May 7, 2007 EX1G

SOU EXTENSION 1 FILED

Feb 7, 2007 EXT1

PAPER RECEIVED

Feb 7, 2007 MAIL

NOA MAILED - SOU REQUIRED FROM APPLICANT

Aug 8, 2006 NOAM

PUBLISHED FOR OPPOSITION

May 16, 2006 PUBO

NOTICE OF PUBLICATION

Apr 26, 2006 NPUB

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 5, 2006 ASCK

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 28, 2006 PREV

ASSIGNED TO LIE

Mar 23, 2006 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 7, 2006 CNSA

AMENDMENT FROM APPLICANT ENTERED

Mar 7, 2006 ACEC

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2006 CRFA

PAPER RECEIVED

Feb 27, 2006 MAIL

NON-FINAL ACTION E-MAILED

Sep 7, 2005 GNRT

NON-FINAL ACTION WRITTEN

Sep 7, 2005 CNRT

ASSIGNED TO EXAMINER

Aug 31, 2005 DOCK

NEW APPLICATION ENTERED

Feb 9, 2005 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

PHYTACTYL